↓ Skip to main content

Azapirones versus placebo for panic disorder in adults

Overview of attention for article published in Cochrane database of systematic reviews, September 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
130 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Azapirones versus placebo for panic disorder in adults
Published in
Cochrane database of systematic reviews, September 2014
DOI 10.1002/14651858.cd010828.pub2
Pubmed ID
Authors

Hissei Imai, Aran Tajika, Peiyao Chen, Alessandro Pompoli, Giuseppe Guaiana, Mariasole Castellazzi, Irene Bighelli, Francesca Girlanda, Corrado Barbui, Markus Koesters, Andrea Cipriani, Toshi A Furukawa

Abstract

Panic disorder is common in the general population. It is often associated with other psychiatric disorders, such as drug dependence, major depression, bipolar disorder, social phobia, specific phobia and generalised anxiety disorder. Azapirones are a class of drugs used as anxiolytics. They are associated with less drowsiness, psychomotor impairment, alcohol potentiation and potential for addiction or abuse than benzodiazepines. However, azapirones are not widely used in the treatment of panic disorder and evidence for their efficacy is unclear. It is important to find out if azapirones are effective and acceptable in the treatment of panic disorder.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 129 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 32 25%
Student > Bachelor 18 14%
Student > Ph. D. Student 13 10%
Researcher 12 9%
Student > Doctoral Student 12 9%
Other 22 17%
Unknown 21 16%
Readers by discipline Count As %
Medicine and Dentistry 39 30%
Psychology 21 16%
Nursing and Health Professions 10 8%
Social Sciences 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Other 17 13%
Unknown 28 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2014.
All research outputs
#3,053,295
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#5,413
of 8,923 outputs
Outputs of similar age
#47,218
of 211,760 outputs
Outputs of similar age from Cochrane database of systematic reviews
#144
of 212 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,760 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 212 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.